Heart hole device under the microscope: does it hold up?
NCT ID NCT04034498
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 50 people who have a hole in the wall between their heart's lower chambers (a perimembranous VSD). They received a special device to close the hole without open-heart surgery. Researchers are checking if the device stays in place and closes the hole properly, and if there are any serious side effects like heart block or infection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Occlutech perimembranous VSD occluder (a device to close a hole in the heart)
What this could lead to
If successful, this could confirm that the device is a safe and effective way to close certain heart holes without open-heart surgery.
What could go wrong
This is a follow-up study with only 50 participants, so results may not apply to everyone. Risks include serious complications like heart block or device problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIMEMBRANOUS VENTRICULAR SEPTAL DEFECT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children Health Ireland
Dublin, Ireland
-
City Children Hospital
Ho Chi Minh City, Vietnam
-
Gaziantep University Hospital
Gaziantep, Turkey (Türkiye)
-
Izmir University of Health Sciences Tepecik Training and Research Hospital
Izmir, 35020, Turkey (Türkiye)
-
Kocaeli University Research and Application Hospital
Kocaeli, 41001, Turkey (Türkiye)
-
Osmangazi University Faculty of Medicine Hospital
Eskişehir, 26040, Turkey (Türkiye)
-
Prince of Songkla University
Hat Yai, Thailand
-
Queen Sirikit National Institute of Child Health
Bangkok, Thailand